BioCentury
ARTICLE | Financial News

Chiesi, Pappas launch rare disease-focused VC firm

September 3, 2014 1:20 AM UTC

Chiesi Farmaceutici S.p.A. (Parma, Italy) and A. M. Pappas & Associates launched a new VC firm, Chiesi Ventures, to invest in early stage research on rare and orphan diseases. A. M. Pappas is an inves...